Ganoweberianone A

[(2R,3S,6R)-1,2-dihydroxy-2-methyl-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] (2S,6R)-6-[(5R,10S,13R,14R,15R,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

KOHPJQAINZLZJM-ADOIXGOQSA-N CHEBI:194571 0 Reactome links 1 studies

Metabolite details

Identifier: KOHPJQAINZLZJM-ADOIXGOQSA-N
InChI Key: KOHPJQAINZLZJM-ADOIXGOQSA-N
IUPAC name: [(2R,3S,6R)-1,2-dihydroxy-2-methyl-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]heptan-3-yl] (2S,6R)-6-[(5R,10S,13R,14R,15R,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate
Preferred name: Ganoweberianone A
INN name: —
Synonym: —
ChEBI: CHEBI:194571

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates

Observed in differential profiles

Control_Liver_vs_Treatment_Liver